Drama: OpenAI's class action lawsuit. An open letter AGAINST EU AI legislation. A First: Testing an AI-developed drug on humans. Microsoft Bing’s 3 new AI shopping features
GM, and happy Sunday ! Welcome back to your Sunday side of AI news.
Here’s what we’ve got for ya today:
The People v. OpenAI, a class-action lawsuit
An open letter AGAINST EU AI legislation
A First: Testing AI-developed drug on humans
Microsoft Bing’s 3 new AI shopping features
AI News: The Headliners 🏁
1/ The People v. OpenAI, a class-action lawsuit
[The News] In a proposed class-action lawsuit against OpenAI, it alleges that OpenAI is secretly collecting and using mass quantities of data to level up its LLM chatbot, ChatGPT. 😳
The deets?
The suit was filed on Wednesday in the US District Court for the Northern District of California, claiming that data from social media sites like Snapchat & Reddit, along with a plethora of other websites like Stripe payments, Spotify, & Slack is being used to improve the chatbot.
(This includes data from social media information and chat log data from millions of users who don’t use AI like ChatGPT)
Per the lawsuit, it states that the data included “private information and private conversations, medical data, information about children—essentially every piece of data exchanged on the internet it could take—without notice to the owners or users of such data, much less with anyone's permission.”
Words like “illegal” and “theft” were mentioned multiple times.
Looking forward…The lawsuit proposes a temporary stop to commercial access to and development of OpenAI's products until the company adds more rules and safety measures, such as letting people choose not to have their data collected.
In addition, the lawsuit also seeks financial compensation for people whose data was accessed to train the LLM.
2/ An open letter AGAINST EU AI legislation
1 step forward, 10 steps back…. the proposed EU AI legislation is already receiving backlash.
Here’s the skinny:
[The News] 160 top executives have signed an open letter stating that the proposed legislation will hurt Europe's competitive edge when it comes to AI development.
Why?
One of the letter's three organizers, Cedric O, explained why this was the case to Reuters: the European Parliament's version opted to shift from a risk-based strategy to a technology-based one.
Digging deeper… The letter cautioned that enterprises in the EU and based in the EU would be at a disadvantage due to excessive compliance costs and unfair liability risks if the existing version of the legislation were to be accepted.
Also, there is a chance companies will move their workforces abroad as result, negatively affecting future EU AI development.
For now… The suggestions made in the letter are already in the draft legislation.
Want to sponsor a future newsletter and share your business with our audience of more than 10,000 + readers?
Go ahead and send an email to [daniel@aicyclopedia.com].
This space could be yours…🥳
AI News: The Shorts 🩳
3/ A First: Testing an AI-developed drug on humans
Would you volunteer to be a human tester for an AI-developed drug?
[The News] Insilico Medicine, a Hong Kong-based biotech startup with more than $400 million in funding, created the drug, INS018_055.
The drug's intended application is to treat idiopathic pulmonary fibrosis, a chronic illness that causes lung scarring.
Why now?
According to the National Institute of Health, the condition currently affects about 100,000 people in the U.S. and can lead to death within two to five years if left untreated.
[The Study] The current research for the IPF medication is a 12-week randomized, double-blind, placebo-controlled trial in China.
The hope is that if everything goes well in the first stage, Insilico intends to expand the testing population to 60 participants at 40 sites in the United States and China.
If the current phase two study is successful, it will go on to another study with a larger cohort, and then potentially reach phase three studies with hundreds of participants.
Looking forward… According to Alex Zhavoronkov, the founder/CEO of Insilico Medicine, he states that he is optimistic that the drug will be ready for market in the next few years.
4/ Microsoft Bing’s 3 new AI shopping features
[The News] This week, Microsoft announced new AI that will be integrated into shopping capabilities for Bing search engine and Bing AI chatbot.
What’s new? Here’s the breakdown:
Buying guides: Bing’s GPT-powered AI will automatically generate buying guides, organize the products by categories, and tell you where to buy the items
AI-generated review summaries: Similar to what Amazon is doing, the AI will be used to sum up online product reviews to make buying decisions easier for consumers.
Price match: Find a better price somewhere else? You can now request a price match from certain retailers, even after the price drops. Microsoft plans on adding more retailers overtime.
It looks like shopping on Bing is going to get a bit more AI-nteresting 😁
Your AI News Break 🥳
AI News Tid Bits…
👉🏻 $1.3 BILLION. That’s how much AI startup Inflection AI has raised from investors like Microsoft and Nvidia. Their revolutionary chatbot? Pi Ai.
👉🏻 The president of Microsoft, Brad Smith, has left his big, comfy, corporate chair to visit Europe. His goal? To help shape AI regulation.
👉🏻 Sex robots and consent. Is it necessary? Some say it will promote rape culture. Others say it will simply simulate rape without “real-world” repercussions.
Top 3 AI tools to use… for YouTube viewers on a time crunch ⏳
1/ Traw AI
Short on time and don't want to miss a thing in that YouTube video?
Save time by using Traw AI to learn and identify the key takeaways from any YouTube video you want to watch.
2/ YTSummary
Using YTSummary, generate AI summaries that are accurate and concise, covering the main points of any video you hope to watch on YouTube.
Like TrawAI, you learn the key insights without ever having to watch the full video.
3/ Opus Clip
Boost your social media exposure by using Opus Clip to repurpose your long-form videos into content for social media platforms like Tiktok, YouTube Shorts, and Reels.
*****
*****
Looking for more AI tools to try? AIcyclopedia includes over 3,000 AI tools and is updated daily with only the very best.
That’s it for today!
If you liked the newsletter, give it a ❤️ and, as always, feel free to sound off in the comment section below 👇🏾
Thank you for choosing us as your AI news source, and don’t forget to follow us on Twitter!
See you next Thursday 👋🏻
